Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × cannabichromene × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Oxycodone 3 Control Groups 2 resiniferatoxin 1 cannabichromene 1 Transcutaneous Electric Nerve Stimulation 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Therapeutic Touch 1 Surveys and Questionnaires 1 Standard of Care 1 Propofol 1 Pharmacogenomic Testing 1 Patient Education as Topic 1 Pain Management 1 Nerve Growth Factor 1 Morphine 1 Midazolam 1 Massage 1 Lidocaine 1 Hydromorphone 1 Ethanol 1 Electroencephalography 1 Duloxetine Hydrochloride 1 Dronabinol 1 Cognitive Behavioral Therapy 1 Cannabidiol 1 Art Therapy 1 Antibodies 1 Acupuncture Therapy 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-03-12

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Active not recruiting

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡